The descriptive epidemiology of female breast cancer: An international comparison of incidence, survival and mortality

_{INTRODUCTION: we present the latest international descriptive epidemiological data for invasive breast cancer amongst women, including incidence, survival and mortality in the worldwide. METHODS: the incidence and mortality statistics presented here for cancers worldwide were taken from the International Agency for Research on Cancer: the Cancer Incidence in five Continents Vol  IX. GLOBOCAN database , presented on may 2011.}

_{The datas of Cancer survival are taken from:Cancer survival in five continents, a worldwide population-based study. Africa is presented by (Setif)Algeria. The Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan). RESULTS: breast cancer is by far the most frequent cancer among women with an estimated 1.38 million new cancer cases diagnosed in 2008   It is now the most common cancer both in developed and developing regions with around 690 000 new cases. The more favorable survival of breast cancer in (high-incidence) developed regions. As a result, breast cancer ranks as the fifth cause of death from cancer overall (458 000 deaths), but it is still the most frequent cause of cancer death in women in both developing (269 000 deaths, 12.7% of total) and developed regions, where the estimated 189 000 deaths.  Five-year relative survival estimates range from 12% in parts of Africa to almost 90% in the United States, Australia and Canada. In Saoudi Arabia the relative survival probabilities at one, three and five years from the incidence  datas were 96%, 83% and 65%, respectively. With the differential linked to a combination of early detection, access to treatment services and cultural barriers. CONCLUSIONS: the future worldwide breast cancer burden will be strongly influenced by large predicted rises in incidence throughout parts of Asia due to an increasingly “westernised” lifestyle. Efforts are underway to reduce the global disparities in survival for women with breast cancer using cost-effective interventions.}